FASEB J. Uncover Your Biological Pathway
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bentzinger, C. F.
Right arrow Articles by Ruegg, M. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bentzinger, C. F.
Right arrow Articles by Ruegg, M. A.
(The FASEB Journal. 2005;19:934-942.)
© 2005 FASEB

Overexpression of mini-agrin in skeletal muscle increases muscle integrity and regenerative capacity in laminin-{alpha}2-deficient mice

C. Florian Bentzinger, Patrizia Barzaghi, Shuo Lin and Markus A. Ruegg1

Biozentrum, University of Basel, Basel, Switzerland

1Correspondence: Biozentrum, University of Basel, Klingelbergstrasse 70, CH-4056 Basel, Switzerland. E-mail: markus-a.ruegg{at}unibas.ch

Mutations in the gene encoding the {alpha}2 subunit of laminins cause the severe "merosin-deficient congenital muscular dystrophy" (MDC1A). We have recently shown that overexpression of a miniaturized form of the molecule agrin (mini-agrin) counteracts the disease in dyW/dyW mice, a model for MDC1A. However, these mice express some residual truncated laminin-{alpha}2, suggesting that the observed amelioration might be due to mini-agrin’s presenting the residual laminin-{alpha}2 to its receptors. Here we show that the mini-agrin counteracts the disease in dy3K/dy3K mice, which are null for laminin-{alpha}2. As in dyW/dyW mice, mini-agrin improves both the function and structure of muscle. We show that muscle regeneration after injury is severely impaired in dy3K/dy3K mice but is restored in the mini-agrin-expressing littermates. In summary, our results 1) show that the direct linkage of muscle basal lamina with the sarcolemma is the basis of mini-agrin-mediated amelioration and 2) provide unprecedented evidence that this linkage is important for proper regeneration of muscle fibers after injury. Our findings thus suggest that treatment with mini-agrin might be beneficial over the entire spectrum of the MDC1A disease, whose severity inversely correlates with expression levels and the size of the truncation in laminin-{alpha}2.—Bentzinger, C. F., Barzaghi, P., Lin, S., Ruegg, M. A., Overexpression of mini-agrin in skeletal muscle increases muscle integrity and regenerative capacity in laminin-{alpha}2-deficient mice.


Key Words: muscular dystrophy • laminin-{alpha}2 deficiency • muscle regeneration




This article has been cited by other articles:


Home page
Am. J. Pathol.Home page
R. Xu, S. DeVries, M. Camboni, and P. T. Martin
Overexpression of Galgt2 Reduces Dystrophic Pathology in the Skeletal Muscles of Alpha Sarcoglycan-Deficient Mice
Am. J. Pathol., July 1, 2009; 175(1): 235 - 247.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
J. W. Day
Congenital muscular dystrophy in a new age
Neurology, July 29, 2008; 71(5): 308 - 309.
[Full Text] [PDF]


Home page
Am. J. Pathol.Home page
R. Xu, K. Chandrasekharan, J. H. Yoon, M. Camboni, and P. T. Martin
Overexpression of the Cytotoxic T Cell (CT) Carbohydrate Inhibits Muscular Dystrophy in the dyW Mouse Model of Congenital Muscular Dystrophy 1A
Am. J. Pathol., July 1, 2007; 171(1): 181 - 199.
[Abstract] [Full Text] [PDF]


Home page
JCBHome page
S. Meinen, P. Barzaghi, S. Lin, H. Lochmuller, and M. A. Ruegg
Linker molecules between laminins and dystroglycan ameliorate laminin-{alpha}2-deficient muscular dystrophy at all disease stages
J. Cell Biol., March 26, 2007; 176(7): 979 - 993.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
P. Scotton, D. Bleckmann, M. Stebler, F. Sciandra, A. Brancaccio, T. Meier, J. Stetefeld, and M. A. Ruegg
Activation of Muscle-specific Receptor Tyrosine Kinase and Binding to Dystroglycan Are Regulated by Alternative mRNA Splicing of Agrin
J. Biol. Chem., December 1, 2006; 281(48): 36835 - 36845.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2005 by The Federation of American Societies for Experimental Biology.